“What should happen before asymptomatic men decide whether or not to have a psa test?” A report on three community juries

Medical Journal of Australia

Volumn 203, Issue 8, 2015, Pages 335.e1-335.e6

  Degeling, Chris ^a   Rychetnik, Lucie ^b   Pickles, Kristen ^a   Thomas, Rae ^c   Doust, Jennifer A ^c   Gardiner, Robert A ^d   Glasziou, Paul ^c   Newson, Ainsley J ^a   Carter, Stacy M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

^c BOND UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; COMMUNITY JURY RESEARCH; DECISION MAKING; FEMALE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; MALE; MEDICAL INFORMATION; PROSTATE BIOPSY; PROSTATE SPECIFIC ANTIGEN TESTING; RESEARCH; SCREENING TEST; AUSTRALIA; BLOOD; GENERAL PRACTICE; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PROSTATIC NEOPLASMS;

AGED; ATTITUDE OF HEALTH PERSONNEL; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84945218243     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja15.00164     Document Type: Article

References (23)

1. Barry MJ. Screening for prostate cancer — the controversy that refuses to die. N Engl J Med 2009; 360: 1351-1354
2. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981-990
3. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2011; 155: 762-771
4. Ilic D, O’Connor D, Green S, Wilt TJ. Screening for prostate cancer: an updated Cochrane systematic review. BJU Int 2011; 107: 882-891
5. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-613
6. Brett AS, Ablin RJ. Prostate-cancer screening — what the US Preventive Services Task Force left out. N Engl J Med 2011; 365: 1949-1951
7. Moyer VA. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-134
8. Urological Society of Australia and New Zealand. PSA testing policy 2009. http://www.usanz.org.au/uploads/2 9168/ufiles/USANZ_2009_PSA_Testing_Policy_Final1.pdf (accessed Jul 2015)
9. Prostate Cancer Foundation of Australia and Cancer Council Australia; PSA Testing Guidelines Expert Advisory Panel. Draft clinical practice guidelines PSA testing and early management of test-detected prostate cancer. Sydney: Cancer Council Australia, 2014. http://wiki.cancer.org.au/australia/Guidelines:PSA_Testing/Guideline_development_process (accessed Jul 2015)
10. National Health and Medical Research Council. PSA testing for prostate cancer in asymptomatic men: information for health practitioners. 2014. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/men4d_psa_testing_asymptomatic_men_140304.pdf (accessed Jul 2015)
11. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 8th ed. Melbourne: RACGP, 2012. http://www.racgp.org.au/your-practice/guidelines/redbook/ (accessed Jul 2015)
12. Degeling C, Carter SM, Lychetnik L. Which public and why deliberate? — A scoping review of public deliberation in public health and health policy research. Soc Sci Med 2015; 131: 114-121
13. Rychetnik L, Doust J, Thomas R, et al. Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening — a qualitative analysis. BMJ Open 2014; 4: e004682
14. Paul C, Nicholls R, Priest P, McGee R. Making policy decisions about population screening for breast cancer: the role of citizens’ deliberation. Health Policy 2008; 85: 314-320
15. Wollin D, Loeb S. Patient perceptions and shared decisions about PSA screening. Rev Urol 2013; 15: 206-207
16. Knight SJ. Decision making and prostate cancer screening. Urol Clin North Am 2014; 41: 257-266
17. Lenaghan J, New B, Mitchell E. Setting priorities: is there a role for citizens’ juries? BMJ 1996; 312: 1591
18. Center for Values, Ethics and the Law in Medicine, University of Sydney. Project 5: Prostate screening from the perspective of citizens [website]. 2014. http://cancerscreeningethics.org/prostate-screening-projects/project-5-community-juries (accessed Jul 2015)
19. Entwistle VA, Carter SM, Trevena L, et al. Communicating about screening. BMJ 2008; 337: a1591-1593
20. Howard K, Brenner AT, Lewis C, et al. A comparison of US and Australian men’s values and preferences for PSA screening. BMC Health Serv Res 2013; 13: 388
21. Gattellari M, Ward JE. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening. J Med Screen 2004; 11: 165-169
22. Australian Bureau of Statistics. Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG), 2011. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/1249.0MainþFeatures12011?OpenDocument (accessed Jul 2015)
23. Australian Bureau of Statistics. SEIFA 2011. http://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001 (accessed Jul 2015).